Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
22126
CAS Number:
4342-03-4
Dacarbazine
Purity:
≥ 98 % (T)(HPLC)
Synonym(s):
5-(3,3-Diméthyltriazéno)imidazole-4-carboxamide, DTIC
Documents
$129.19 /1G
Taille
Request Bulk Quote
Informations sur le produit

Dacarbazine is a potent antineoplastic agent widely utilized in the treatment of various cancers, including melanoma, Hodgkin's lymphoma, and soft tissue sarcomas. This compound functions as an alkylating agent, disrupting DNA synthesis and ultimately inhibiting tumor growth. Its unique structure, characterized by the presence of a diazene group, enhances its reactivity, making it effective in targeting rapidly dividing cancer cells. Dacarbazine is often administered in combination with other chemotherapeutic agents, maximizing therapeutic efficacy and improving patient outcomes.

In addition to its established use in oncology, Dacarbazine is also being explored in clinical trials for other malignancies, showcasing its versatility in cancer treatment protocols. Researchers appreciate its relatively favorable safety profile compared to other chemotherapeutics, allowing for better patient tolerance. With ongoing studies investigating its potential in combination therapies, Dacarbazine remains a critical component in the evolving landscape of cancer treatment, offering hope for improved survival rates and quality of life for patients.

Numéro CAS 
4342-03-4
Formule moléculaire
C6H10N6O
Poids moléculaire 
182.19
Point de fusion 
255 °C (déc.)
Informations générales
Numéro CAS 
4342-03-4
Formule moléculaire
C6H10N6O
Poids moléculaire 
182.19
Point de fusion 
255 °C (déc.)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Dacarbazine is widely utilized in research focused on

  • Cancer Treatment: Primarily used as a chemotherapy agent for treating melanoma and Hodgkin's lymphoma, offering a vital option for patients with these conditions.
  • Clinical Trials: Frequently involved in clinical studies to assess its efficacy in combination therapies, helping to advance cancer treatment protocols.
  • Pharmaceutical Development: Serves as a reference compound in drug formulation research, aiding in the development of new anticancer drugs.
  • Biochemical Research: Utilized in laboratory settings to study cellular responses to chemotherapy, providing insights into cancer cell behavior and resistance mechanisms.
  • Veterinary Medicine: Occasionally explored for use in treating certain cancers in animals, expanding its application beyond human medicine.

Citations